Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Fang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the Chinese Medical Association : JCMA|May 13, 2006
Primary cardiac lymphomaShu-Ching Hsueh, Ming-Teng Chung, Richard Fang, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expressionNaveen Kumar Tangudu, Raquel Buj, Hui Wang, et al.
EMBO Reports|June 13, 2025
ATR promotes mTORC1 activity via de novo cholesterol synthesisNaveen Kumar Tangudu, Alexandra N Grumet, Richard Fang, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
ATR promotes mTORC1 activity via <i>de novo</i> cholesterol synthesisNaveen Kumar Tangudu, Alexandra N Grumet, Richard Fang, et al.
Cancer Research Communications|April 16, 2024
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 ExpressionNaveen Kumar Tangudu, Raquel Buj, Hui Wang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the Chinese Medical Association : JCMA|May 13, 2006
Primary cardiac lymphomaShu-Ching Hsueh, Ming-Teng Chung, Richard Fang, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expressionNaveen Kumar Tangudu, Raquel Buj, Hui Wang, et al.
EMBO Reports|June 13, 2025
ATR promotes mTORC1 activity via de novo cholesterol synthesisNaveen Kumar Tangudu, Alexandra N Grumet, Richard Fang, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
ATR promotes mTORC1 activity via <i>de novo</i> cholesterol synthesisNaveen Kumar Tangudu, Alexandra N Grumet, Richard Fang, et al.
Cancer Research Communications|April 16, 2024
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 ExpressionNaveen Kumar Tangudu, Raquel Buj, Hui Wang, et al.
Pageof 1